back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-03-04 06:33 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
| Filed 2023-03-04 00:53 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Richer, Sylvain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
750,000 | ||
| Filed 2023-03-04 00:53 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Richer, Sylvain
5 - Senior Officer of Issuer
Holder: Placements Sylvain Richer Inc. (Indirect Ownership)
|
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
| Filed 2023-03-04 00:45 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Boudreault, Marc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
750,000 | ||
| Filed 2023-03-04 00:45 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Boudreault, Marc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
|
1,013,000 | ||
| Filed 2023-03-04 00:44 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Boudreault, Marc
5 - Senior Officer of Issuer
Holder: Fiducie Boudreault Decoste (Indirect Ownership)
|
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
|
1,480,000 | ||
| Filed 2023-03-04 00:34 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Pierre B., Lafrenière
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2023-03-04 00:04 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Aird, Sylvain
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2023-03-04 00:04 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Aird, Sylvain
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
35,714 | ||
| Filed 2023-03-04 00:03 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Aird, Sylvain
4 - Director of Issuer
Direct Ownership
|
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
|
71,428 | ||
| Filed 2023-03-03 23:54 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
|
4,748,000 | ||
| Filed 2023-03-03 23:48 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Dellafera, Frank J.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2023-03-03 23:47 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Dellafera, Frank J.
4 - Director of Issuer
Holder: Alfera Pharmaceuticals, LLC (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
21,428 | ||
| Filed 2023-03-03 23:47 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Dellafera, Frank J.
4 - Director of Issuer
Holder: Alfera Pharmaceuticals, LLC (Indirect Ownership)
|
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
|
42,857 | ||
| Filed 2023-03-03 16:48 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
||
| Filed 2023-03-03 16:48 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
| Filed 2023-03-03 07:12 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|